MedMesh.i
Curation
PubMed
Racine
Curation
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Selegiline »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Selection, Genetic < Selegiline < Selenoproteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
001077 (2003) Olivier Rascol [France]Monoamine oxidase inhibitors--is it time to up the TEMPO?
001134 (2002) Selegiline: a second look. Six years later: too risky in Parkinson's disease.
001204 (2001) N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. PoindronThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
001493 (1997) N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L MontastrucA dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
001525 (1996) J L Montastruc [France] ; O. Rascol ; J M SenardNew directions in the drug treatment of Parkinson's disease.
001606 (1995) H. Lefebvre [France] ; C. Noblet ; N. Moore ; L M WolfPseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
001675 (????) [Monotherapy trial with selegiline in de novo parkinsonian patients] Members of the French research group for testing selegiline in early Parkinson disease].
001704 (1993) H. Allain [France] ; P. Pollak ; H C NeukirchSymptomatic effect of selegiline in de novo Parkinsonian patients. The French Selegiline Multicenter Trial.
001750 (????) J L Montastruc [France]Recent advances in the clinical pharmacology of Parkinson's disease.
001759 (1991) H. Allain [France] ; J. Cougnard ; H C NeukirchSelegiline in de novo parkinsonian patients: the French selegiline multicenter trial (FSMT).
001821 (1988) O. Rascol [France] ; J L Montastruc ; J M Senard ; J F Demonet ; M. Simonetta ; A. RascolTwo weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Selegiline" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Selegiline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Selegiline
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024